癫痫孕妇围产期及母体疾病与死亡风险研究
这项基于丹麦、芬兰、冰岛、挪威和瑞典的前瞻性人群登记研究分析了1996年至2017年间4,511,267次单胎分娩,其中35,283次为癫痫母亲。癫痫孕妇的复合严重母体疾病与死亡率为每1000次分娩36.9例,高于无癫痫者的25.4例,死亡风险aOR为3.86。胎儿和婴儿的死亡风险aOR为1.20,严重新生儿疾病风险aOR为1.48。
要点
- 癫痫孕妇的复合严重母体疾病与死亡率为36.9/1000次分娩,高于无癫痫者的25.4/1000次。
- 癫痫孕妇死亡风险aOR为3.86(95% CI 1.48-8.10)。
- 子代死亡风险aOR为1.20,严重新生儿疾病风险aOR为1.48。
核心结论
- 这项跨国研究显示,癫痫孕妇发生严重母体及围产期结局的风险显著更高,妊娠期和产后死亡风险增加。
- 母体癫痫及母体使用抗癫痫发作药物与母体疾病及围产期死亡和疾病风险增加相关。
研究设计与样本
- 前瞻性人群登记研究,在丹麦、芬兰、冰岛、挪威和瑞典进行,时间跨度为1996年1月1日至2017年12月31日。
- 纳入孕22周及以上的所有单胎分娩,排除出生体重或孕周信息缺失或无效的分娩。
- 共识别4,511,267次分娩,其中4,475,984次为无癫痫女性,35,283次为癫痫母亲。
- 暴露为分娩前记录的母体癫痫诊断,以及从受孕至分娩期间任何母体处方配药的抗癫痫发作药物产前暴露。
- 采用多变量广义估计方程(logit链接)计算调整比值比(aOR)和95% CI。
主要发现
- 癫痫队列女性分娩时平均(SD)年龄为29.9(5.3)岁。
- 癫痫女性复合严重母体疾病与死亡率为每1000次分娩36.9例,无癫痫女性为每1000次分娩25.4例。
- 癫痫女性死亡率为每1000次分娩0.23例,无癫痫女性为每1000次分娩0.05例,aOR为3.86(95% CI 1.48-8.10)。
- 母体癫痫与严重子痫前期、栓塞、弥散性血管内凝血或休克、脑血管事件及严重精神健康状况的比值增加相关。
- 癫痫女性的胎儿和婴儿死亡风险aOR为1.20(95% CI 1.05-1.38),严重新生儿疾病风险aOR为1.48(95% CI 1.40-1.56)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Maternal epilepsy is associated with adverse pregnancy and neonatal outcomes. A better understanding of this condition and the associated risk of mortality and morbidity at the time of delivery could help reduce adverse outcomes. OBJECTIVE: To determine the risk of severe maternal and perinatal morbidity and mortality among women with epilepsy. DESIGN, SETTING, PARTICIPANTS: This prospective population-based register study in Denmark, Finland, Iceland, Norway, and Sweden took place between January 1, 1996, and December 31, 2017. Data analysis was performed from August 2022 to November 2023. Participants included all singleton births at 22 weeks' gestation or longer. Births with missing or invalid information on birth weight or gestational length were excluded. The study team identified 4 511 267 deliveries, of which 4 475 984 were to women without epilepsy and 35 283 to mothers with epilepsy. EXPOSURE: Maternal epilepsy diagnosis recorded before childbirth. Prenatal exposure to antiseizure medication (ASM), defined as any maternal prescription fills from conception to childbirth, was also examined. MAIN OUTCOMES AND MEASURES: Composite severe maternal morbidity and mortality occurring in pregnancy or within 42 days postpartum and composite severe neonatal morbidity (eg, neonatal convulsions) and perinatal mortality (ie, stillbirths and deaths) during the first 28 days of life. Multivariable generalized estimating equations with logit-link were used to obtain adjusted odds ratios (aORs) and 95% CIs. RESULTS: The mean (SD) age at delivery for women in the epilepsy cohort was 29.9 (5.3) years. The rate of composite severe maternal morbidity and mortality was also higher in women with epilepsy compared with those without epilepsy (36.9 vs 25.4 per 1000 deliveries). Women with epilepsy also had a significantly higher risk of death (0.23 deaths per 1000 deliveries) compared with women without epilepsy (0.05 deaths per 1000 deliveries) with an aOR of 3.86 (95% CI, 1.48-8.10). In particular, maternal epilepsy was associated with increased odds of severe preeclampsia, embolism, disseminated intravascular coagulation or shock, cerebrovascular events, and severe mental health conditions. Fetuses and infants of women with epilepsy were at elevated odds of mortality (aOR, 1.20; 95% CI, 1.05-1.38) and severe neonatal morbidity (aOR, 1.48; 95% CI, 1.40-1.56). In analyses restricted to women with epilepsy, women exposed to ASM compared with those unexposed had higher odds of severe maternal morbidity (aOR ,1.24; 95% CI, 1.10-1.48) and their neonates had an increased odd of mortality and severe morbidity (aOR, 1.37; 95% CI, 1.23-1.52). CONCLUSION AND RELEVANCE: This multinational study shows that women with epilepsy were at considerably higher risk of severe maternal and perinatal outcomes and increased risk of death during pregnancy and postpartum. Maternal epilepsy and maternal use of ASM were associated with increased maternal morbidity and perinatal mortality and morbidity.
引用
- Razaz N, Igland J, Bjørk MH, et al. Risk of Perinatal and Maternal Morbidity and Mortality Among Pregnant Women With Epilepsy. JAMA Neurol. 2024. PMID: 39102246. doi:10.1001/jamaneurol.2024.2375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。